FACTANKER · measured, cited, anchored official records connected

SUNSHINE BIOPHARMA INC. — Revenue by Fiscal Year

16 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/e0ed87ea-6db7-4225-9428-46b0d693df44/serie/revenue

Fiscal yearRevenuePeriodEvidence
FY 2025$36.3M2025-01-01 – 2025-12-31evidence 0001683168-26-002644
FY 2024$34.9M2024-01-01 – 2024-12-31evidence 0001683168-25-002184
FY 2023$24.1M2023-01-01 – 2023-12-31evidence 0001683168-24-001818
FY 2022$4.3M2022-01-01 – 2022-12-31evidence 0001683168-23-002128
FY 2021$228.4k2021-01-01 – 2021-12-31evidence 0001683168-22-001788
FY 2020$71.4k2020-01-01 – 2020-12-31evidence 0001654954-21-003507
FY 2019$21.1k2019-01-01 – 2019-12-31evidence 0001654954-20-004731
FY 2018$02018-01-01 – 2018-12-31evidence 0001654954-20-004731
FY 2017$02017-01-01 – 2017-12-31evidence 0001654954-19-004354
FY 2016$02016-01-01 – 2016-12-31evidence 0001654954-17-003365
FY 2015$1.7k2015-01-01 – 2015-12-31evidence 0001354488-16-006700
FY 2014$02014-01-01 – 2014-12-31evidence 0001354488-15-001081
FY 2013$02013-01-01 – 2013-12-31evidence 0001354488-14-001275
FY 2012$02012-01-01 – 2012-12-31evidence 0001354488-14-001275
FY 2011$02009-08-17 – 2012-03-31evidence 0001354488-12-002208
FY 2010$02009-08-17 – 2011-03-31evidence 0001354488-11-001463
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

SUNSHINE BIOPHARMA INC. — all facts · Net Income · Operating Income